Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Rascol · SciRah

Researcher profile · Semantic Scholar

O. Rascol

Share profile

O. Rascol — researcher profile on SciRah

h-index: 103
Works: 606
Citations: 48K

Most-cited papers

LRRK2 in Parkinson disease: challenges of clinical trials
E. Tolosa, M. Vila, C. Klein, O. Rascol
2020Nature Reviews Neurology403 citations
Semantic Scholar
Trial of Cinpanemab in Early Parkinson's Disease.
A. Lang, A. Siderowf, E. Macklin, W. Poewe +22 more
2022New England Journal of Medicine259 citations Open access
Semantic Scholar
Trial of Deferiprone in Parkinson's Disease.
D. Devos, J. Labreuche, O. Rascol, J. Corvol +61 more
2022New England Journal of Medicine190 citations Open access
Semantic Scholar
Amantadine in the treatment of Parkinson's disease and other movement disorders.
O. Rascol, M. Fabbri, W. Poewe
2021Lancet Neurology161 citations Open access
Semantic Scholar
Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study.
A. Foubert-Samier, A. P. Traon, Florian Guillet, M. Le-Goff +5 more
2020Neurobiology of Disease88 citations Open access
Semantic Scholar
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study.
R. Katzenschlager, W. Poewe, O. Rascol, C. Trenkwalder +7 more
2021Parkinsonism & Related Disorders79 citations Open access
Semantic Scholar
A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy
W. Meissner, A. P. Traon, A. Foubert-Samier, G. Galabova +23 more
2020Movement Disorders75 citations Open access
Semantic Scholar
Neurofilament light levels predict clinical progression and death in multiple system atrophy
V. Chelban, Elham Nikram, A. Pérez-Soriano, C. Wilke +45 more
2022Brain : a journal of neurology61 citations Open access
Semantic Scholar
Long‐term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open‐label extensions
J. Ferreira, A. Lees, José-Francisco Rocha, W. Poewe +2 more
2019European Journal of Neurology59 citations Open access
Semantic Scholar
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study
W. Poewe, D. Volc, K. Seppi, R. Medori +17 more
2021Journal of Parkinson's Disease50 citations Open access
Semantic Scholar
COMT Inhibitors in the Management of Parkinson’s Disease
M. Fabbri, J. Ferreira, O. Rascol
2022CNS Drugs45 citations
Semantic Scholar
Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach
A. Lees, E. Tolosa, F. Stocchi, J. Ferreira +3 more
2023Expert Review of Neurotherapeutics44 citations Open access
Semantic Scholar
Off-time Treatment Options for Parkinson’s Disease
M. Fabbri, Raquel Barbosa, O. Rascol
2023Neurological Therapeutics44 citations Open access
Semantic Scholar
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone
P. Jenner, J. Rocha, J. Ferreira, O. Rascol +1 more
2021Expert Review of Neurotherapeutics43 citations Open access
Semantic Scholar
On‐Demand Therapy for OFF Episodes in Parkinson's Disease
C. Olanow, W. Poewe, O. Rascol, F. Stocchi
2021Movement Disorders43 citations
Semantic Scholar
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study
M. Santin, P. Voulleminot, A. Vrillon, É. Hainque +29 more
2020Movement Disorders43 citations
Semantic Scholar
The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant.
P. LeWitt, Stephen D. Aradi, R. Hauser, O. Rascol
2020Parkinsonism & Related Disorders42 citations Open access
Semantic Scholar
A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease
O. Rascol, R. Medori, C. Baayen, P. Such +1 more
2022Movement Disorders39 citations Open access
Semantic Scholar
Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease
J. Ferreira, W. Poewe, O. Rascol, F. Stocchi +5 more
2022Movement Disorders38 citations Open access
Semantic Scholar
Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
R. Hauser, N. Hattori, Hubert H. Fernandez, S. Isaacson +8 more
2021Journal of Parkinson's Disease36 citations Open access
Semantic Scholar
Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”
T. Outeiro, R. Alcalay, A. Antonini, J. Attems +13 more
2023Movement Disorders35 citations Open access
Semantic Scholar
Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis
A. Jucaite, Z. Cselényi, W. Kreisl, E. Rabiner +15 more
2021Movement Disorders35 citations Open access
Semantic Scholar
Challenges and Perspectives in the Management of Late-Stage Parkinson’s Disease
M. Fabbri, L. A. Kauppila, J. Ferreira, O. Rascol
2020Journal of Parkinson's Disease31 citations Open access
Semantic Scholar
Broad white matter impairment in multiple system atrophy
N. Del Campo, Owen R. Phillips, F. Ory-Magne, C. Brefel-Courbon +8 more
2020Human Brain Mapping28 citations Open access
Semantic Scholar
Describing complex disease progression using joint latent class models for multivariate longitudinal markers and clinical endpoints
C. Proust-Lima, Tiphaine Saulnier, Viviane Philipps, A. P. Traon +4 more
2022Statistics in Medicine24 citations Open access
Semantic Scholar
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study
M. Fabbri, Clémence Leung, G. Baille, M. Béreau +16 more
2021Parkinsonism & Related Disorders24 citations Open access
Semantic Scholar
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO Trial
O. Rascol, Valérie Cochen de Cock, Anne Pavy-Le Traon, A. Foubert-Samier +18 more
2021Movement Disorders24 citations Open access
Semantic Scholar
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
J. Rocha, G. Ebersbach, A. Lees, E. Tolosa +8 more
2021Frontiers in Neurology24 citations Open access
Semantic Scholar
Orphan drug clinical development.
O. Blin, Marie-Noëlle Lefebvre, O. Rascol, J. Micallef
2020The´rapie (Paris)24 citations Open access
Semantic Scholar
The Unified Multiple System Atrophy Rating Scale (UMSARS): Status, Critique and Recommendations
F. Krismer, J. Palma, G. Calandra-Buonaura, I. Stanković +23 more
2022Movement Disorders23 citations Open access
Semantic Scholar
Parkinson’s Disease Drug Development Since 1999: A Story of Repurposing and Relative Success
Deirdre M. Boucherie, G. Duarte, Tiago Machado, Patrícia Faustino +3 more
2021Journal of Parkinson's Disease22 citations Open access
Semantic Scholar
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
O. Rascol, L. Tönges, T. Devries, M. Jaros +2 more
2022Parkinsonism & Related Disorders21 citations Open access
Semantic Scholar
Cerebrospinal Fluid Levels of Kininogen‐1 Indicate Early Cognitive Impairment in Parkinson's Disease
I. Markaki, S. Bergström, Panagiota Tsitsi, Julia Remnestål +14 more
2020Movement Disorders21 citations Open access
Semantic Scholar
Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial.
Jean-Christophe Corvol, F. Durif, W. Meissner, J. Azulay +16 more
2019Parkinsonism & Related Disorders21 citations Open access
Semantic Scholar
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease
S. Pinto, Adelheid Nebel, J. Rau, R. Espesser +48 more
2022Movement Disorders19 citations Open access
Semantic Scholar
The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers
E. Tolosa, G. Ebersbach, J. Ferreira, O. Rascol +6 more
2021Journal of Parkinson's Disease19 citations Open access
Semantic Scholar
Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout.
Tiphaine Saulnier, Viviane Philipps, W. Meissner, O. Rascol +3 more
2021Methods19 citations
Semantic Scholar
Brain 5‐HT1A Receptor Binding in Multiple System Atrophy: An [18F]‐MPPF PET Study
M. Meyer, F. Lamare, J. Asselineau, A. Foubert-Samier +11 more
2020Movement Disorders17 citations
Semantic Scholar
An Item Response Theory analysis of the Unified Multiple System Atrophy Rating Scale.
A. Foubert-Samier, Anne Pavy-Le Traon, Tiphaine Saulnier, M. Le-Goff +5 more
2021Parkinsonism & Related Disorders16 citations Open access
Semantic Scholar
β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study
S. de Germay, C. Conte, O. Rascol, J. Montastruc +1 more
2020CNS Drugs15 citations
Semantic Scholar
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
K. Chaudhuri, P. Odin, J. Ferreira, A. Antonini +8 more
2022BMC Neurology14 citations Open access
Semantic Scholar
The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis
M. van Munster, Johanne Stümpel, Franziska Thieken, Florin Ratajczak +6 more
2022Journal of Parkinson's Disease14 citations Open access
Semantic Scholar
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
A. Shadrin, Sören Mucha, D. Ellinghaus, Mary B Makarious +32 more
2020Movement Disorders14 citations Open access
Semantic Scholar
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson’s Disease (PSYCHO-STIM II)
M. Boussac, C. Arbus, H. Klinger, A. Eusebio +26 more
2021Journal of Parkinson's Disease13 citations Open access
Semantic Scholar
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial
Jean-Christophe Corvol, J. Azulay, B. Bosse, Y. Dauvilliers +11 more
2021Movement Disorders12 citations Open access
Semantic Scholar
Ambulatory blood pressure and drug treatment for orthostatic hypotension as predictors of mortality in patients with multiple system atrophy
Anne Pavy-Le Traon, A. Foubert-Samier, F. Ory-Magne, M. Fabbri +4 more
2021European Journal of Neurology12 citations
Semantic Scholar
Utilization Patterns of Amantadine in Parkinson’s Disease Patients Enrolled in the French COPARK Study
O. Rascol, L. Negre-pages, P. Damier, A. Delval +7 more
2020Drugs & Aging12 citations Open access
Semantic Scholar
Personality Dimensions Are Associated with Quality of Life in Fluctuating Parkinson’s Disease Patients (PSYCHO-STIM)
M. Boussac, C. Arbus, J. Dupouy, Estelle Harroch +21 more
2020Journal of Parkinson's Disease12 citations Open access
Semantic Scholar
European survey on national training activities in clinical research
A. Magnin, V. Iversen, G. Calvo, B. Cecetková +15 more
2019Trials12 citations Open access
Semantic Scholar
Reversible myoclonus‐ataxia encephalitis related to anti‐mGLUR1 autoantibodies
C. Gollion, J. Dupouy, Meryl Roberts, M. Simonetta-Moreau +4 more
2019Movement Disorders12 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Meissner×16
Invite
W. Meissner — researcher profile on SciRah
M. Fabbri×11
Invite
M. Fabbri — researcher profile on SciRah
A. Foubert-Samier×11
Invite
A. Foubert-Samier — researcher profile on SciRah
W. Poewe×10
Invite
W. Poewe — researcher profile on SciRah

×8

Invite

J. Ferreira — researcher profile on SciRah

Invite

F. Stocchi — researcher profile on SciRah

F. Ory-Magne×6

Invite

F. Ory-Magne — researcher profile on SciRah

Invite

A. Antonini — researcher profile on SciRah

Invite

D. Maltête — researcher profile on SciRah

Invite

E. Tolosa — researcher profile on SciRah

Invite

J. Corvol — researcher profile on SciRah

C. Tranchant×5

Invite

C. Tranchant — researcher profile on SciRah